LPL Financial
ABBV icon

LPL Financial’s AbbVie ABBV Stock Holding History

LPL Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,300
Closed -$409K – 5345
2024
Q4 		$409K Buy
+2,300
New +$423K ﹤0.01% 4265

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LPL Financial's ABBV Position: Q1 2026 in Review

LPL Financial increased its AbbVie (ABBV) stake by 2.4% in Q1 2026, buying an estimated $20.4M and bringing the position to 3,945,266 shares worth $858M. The position accounts for 0.23% of the portfolio, ranked #93.

LPL Financial first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $880M in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • LPL Financial held 3,945,266 shares of AbbVie worth $858M as of Q1 2026.
  • LPL Financial bought 92,169 AbbVie shares in Q1 2026, an estimated $20.4M.
  • AbbVie made up 0.23% of LPL Financial's portfolio in Q1 2026, its #93 holding.
  • LPL Financial first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • LPL Financial's AbbVie position peaked at $880M in Q4 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.